Description: Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes OpenAI's ChatGPT. The company also develops Dr. GENAI, a personal AI medical chatbot designed to give people to obtain fast and personalized medical information based on a person's unique medical condition. In addition, the company developing Brain Age, an electroencephalogram-based (EEG) machine-learning solution to detect an individual's brain age for use in clinic and at-home. It has a collaboration agreement with EIREX technology for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. The company is headquartered in Toronto, Canada.
Home Page: www.diagnamed.com
82 Richmond Street East
Toronto,
ON
M5C 1P1
Canada
Phone:
416 800 2684
Officers
| Name | Title |
|---|---|
| Mr. Fabio Chianelli | Chairman, President & CEO |
| Mr. Jing Peng C.A., CPA, CA, CPA, MMPA | Chief Financial Officer |
| Mr. Andrew Newbury CPA | Corporate Secretary |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Technology |
| GIC Sub-Industry: | Health Care Technology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 14.5845 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |